Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Fastnet Equity closing in on potential pharma deal

Fastnet Equity has requested its shares to be suspended as it closes in on a potential deal to buy Amryt Pharmaceuticals DAC.
Fastnet Equity closing in on potential pharma deal
The firm said it was in very advanced discussions with Amryt Pharmaceuticals DAC

Fastnet Equity (LON:FAST) has requested its shares to be suspended as it closes in on a potential deal to buy  Amryt Pharmaceuticals DAC.

As reported last year Fastnet drew a line under its oil and gas business and started to look for healthcare businesses to acquire.

The company says it's now in very advanced discussions with Amryt Pharmaceuticals DAC.

If this acquisition proceeds, which would constitute a reverse takeover, the enlarged group will become a late stage, specialty biopharmaceutical, it said today.

A further announcement will be made in due course.

Giles_55af4ddca6481.jpg
Why Invest In Amryt Pharmaceuticals? Read More Here

Register here to be notified of future AMYT Company articles
View full AMYT profile

Amryt Pharmaceuticals Timeline

Related Articles

sareum-test-tubes.png
March 10 2016
November saw the Finland-based life sciences firm list on the London Exchange, raising €14.2mln.
Heart-cells.jpg
April 13 2016
Jim Phillips, Midatech’s chief executive, said Zuplenz offers relief from some of the most debilitating side-effects of common cancer treatments. Generically called ondansetron, the oral soluble film eases the problem of gritty residue, having to wear a patch and sedative side effects of dissolving tablets and injections.
shutterstock_152199281_56fd078fe84f7.jpg
March 31 2016
Amryt Pharmaceuticals is coming to the market following a reverse takeover deal with the investment firm Fastnet Equities. Here boss Joseph Wiley tells us a little bit more about the AIM newcomer.

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.